Immuron Limited (IMRN)
NASDAQ: IMRN
· Real-Time Price · USD
1.75
-0.02 (-1.10%)
At close: Jun 12, 2025, 3:54 PM
1.75
-0.05%
After-hours: Jun 12, 2025, 04:00 PM EDT
-1.10% (1D)
Bid | 1.71 |
Market Cap | 10.03M |
Revenue (ttm) | 7.82M |
Net Income (ttm) | -9.78M |
EPS (ttm) | -0.87 |
PE Ratio (ttm) | -2.01 |
Forward PE | -86 |
Analyst | Buy |
Ask | 1.98 |
Volume | 11,224 |
Avg. Volume (20D) | 28,153 |
Open | 1.83 |
Previous Close | 1.77 |
Day's Range | 1.75 - 1.83 |
52-Week Range | 1.50 - 2.87 |
Beta | 0.51 |
About IMRN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IMRN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IMRN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+8.59%
Immuron shares are trading higher after the compan...
Unlock content with
Pro Subscription
4 months ago
+1.52%
Immuron shares are trading higher after the company announced that it has submitted its Phase 2 study report to the FDA and is preparing for the the next steps toward its Phase 3 trial.

2 years ago · proactiveinvestors.co.uk
Immuron CEO highlights strong sales growth in business update presentationImmuron Ltd (NASDAQ:IMRN, ASX:IMC) CEO Steven Lydeamore highlighted the strong growth in sales of oral immunotherapeutic products in the company's February 2023 business update presentation for invest...

3 years ago · investorplace.com
IMRN Stock Alert: What Is the Huge Catalyst Sending Immuron Soaring?Today marks one of the best days for IMRN stock in a long time, with shares surging nearly 50% on the back of some impressive news. The post IMRN Stock Alert: What Is the Huge Catalyst Sending Immuron...